Thoracic Surgery Department, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, People's Republic of China.
Clin Chim Acta. 2010 Jun 3;411(11-12):846-52. doi: 10.1016/j.cca.2010.02.074. Epub 2010 Mar 16.
MicroRNAs (miRNAs) are a class of small non-coding RNAs regulating gene expression that play roles in the pathogenesis of human diseases, including malignancy. miR-21, a commonly overexpressed miRNA in very diverse types of malignancies, may affect tumor progression through targeting tumor suppressor genes. We identified the role of miR-21 in non-small cell lung cancer (NSCLC) and to clarify the regulation of PTEN by miR-21 and determine mechanisms of this regulation.
Expression of miR-21 and PTEN in 20 paired NSCLC and adjacent non-tumor lung tissues was investigated by qRT-PCR and western blot, respectively. The effect of miR-21 on PTEN expression was assessed in NSCLC cell lines with miR-21 inhibitor to decrease miR-21 expression. Furthermore, the roles of miR-21 in cell growth and invasion were analyzed with miR-21 inhibitor-transfected cells.
miR-21 was overexpressed in tumor tissues relative to adjacent non-tumor tissues. Notably, patients with advanced clinical TNM stage (n=16) or distal metastasis (n=5) demonstrated higher miR-21 expression than those without them (n=26, or n=37) (p<0.05, or p<0.001). Tumor tissues showed an inverse correlation between miR-21 and PTEN protein. miR-21 inhibitor transfection increased a luciferase-reporter activity containing the PTEN-3'-UTR construct and increased PTEN protein but not PTEN-mRNA levels in NSCLC cell lines. Finally, miR-21 inhibitor-transfected cells exhibited markedly reduced cell growth and invasive characteristics.
miR-21 post-transcriptionally down-regulates the expression of tumor suppressor PTEN and stimulates growth and invasion in NSCLC. It may be a potential therapeutic target for NSCLC.
微小 RNA(miRNA)是一类调节基因表达的小非编码 RNA,在包括恶性肿瘤在内的人类疾病的发病机制中发挥作用。miR-21 是各种恶性肿瘤中普遍过表达的 miRNA 之一,可能通过靶向肿瘤抑制基因影响肿瘤进展。我们确定了 miR-21 在非小细胞肺癌(NSCLC)中的作用,并阐明了 miR-21 对 PTEN 的调节作用及其调节机制。
通过 qRT-PCR 和 Western blot 分别检测 20 对 NSCLC 组织及其相邻非肿瘤肺组织中 miR-21 和 PTEN 的表达。用 miR-21 抑制剂降低 miR-21 表达,评估 miR-21 对 NSCLC 细胞系中 PTEN 表达的影响。用 miR-21 抑制剂转染的细胞分析 miR-21 在细胞生长和侵袭中的作用。
miR-21 在肿瘤组织中相对于相邻非肿瘤组织表达上调。值得注意的是,临床分期较晚(n=16)或有远处转移(n=5)的患者 miR-21 表达高于无远处转移的患者(n=26,或 n=37)(p<0.05,或 p<0.001)。肿瘤组织中 miR-21 与 PTEN 蛋白呈负相关。miR-21 抑制剂转染增加了含有 PTEN-3'-UTR 构建体的荧光素酶报告基因活性,并增加了 NSCLC 细胞系中的 PTEN 蛋白,但不增加 PTEN-mRNA 水平。最后,miR-21 抑制剂转染的细胞表现出明显降低的细胞生长和侵袭特征。
miR-21 在后转录水平下调肿瘤抑制基因 PTEN 的表达,并刺激 NSCLC 中的生长和侵袭。它可能是 NSCLC 的一个潜在治疗靶点。